Centene downgraded its 2024 adjusted earnings per share target this week to greater than $6.60, reflecting its view of Medicaid redeterminations, its Medicare bid strategy and business investments, according to its Q1 financial results.
This compares to an earlier forecast of $7.15 per share, according to Reuters.
